A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Clinical trial NCT04682431 · TERMINATED
Trial details
- NCT number
- NCT04682431
- Sponsor
- Ikena Oncology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2023-08-25
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.